Upload
mmanocchia
View
810
Download
1
Tags:
Embed Size (px)
DESCRIPTION
HMG Patent
Citation preview
CONFIDENTIAL & PROPRIETARY
Impact Pro HMGs: Using information to further describe population health
Presentation at the Ingenix Health Care ConferenceMichael Manocchia, Ph.D. Director, Outcomes and [email protected](work)781-419-8427
May 15, 2008 ● Orlando, FL
© Ingenix, Inc. 2CONFIDENTIAL & PROPRIETARY
Agenda Topics
Introduction and IPRO refresher Self Report Domains Current Self Report IPRO incorporation
Impact Pro Active Filtering Case Definitions and Business rules Limitations in current self report IPRO approach
Introduction of HMG Making the business case HMG introduction Self Report standardization HMG testing with obesity, smoking and nutrition
Additional Questions
© Ingenix, Inc. 3CONFIDENTIAL & PROPRIETARY
Impact Pro – Features
Impact Pro is a multi-dimensional, episode-based predictive modeling suite
Accepts readily available information, including medical claims, pharmacy claims, and lab test results for modeling
Leverages Symmetry’s ETGs to build clinically homogenous markers of future risk
Predicts both future expenditures and calculates the probability of a hospitalization
Multiple predictive horizons available based upon available data and business needs
Transparent – allows users to easily understand the clinical and utilization factors affecting a member’s risk
Characterizes members along a number of dimensions, including clinical details and gaps in care
© Ingenix, Inc. 4CONFIDENTIAL & PROPRIETARY
Business Applications for Impact Pro
Medical Management Identify and manage the right patients, at the right time, with the right
intervention
Identify members at greatest risk for future healthcare problems Understand key clinical drivers of risk – support steerage to appropriate
programs Identify care opportunities – members with gaps in care, complications and
co-morbidities
UnderwritingSet the right premium rate, attract and retain good business, promote stability
and profit
Historically, underwriters have used experience and other factors (age/gender, geographic and industry factors) to set healthcare premiums for individuals & groups
Information on health risk for groups and individuals is used to enhance the underwriting process
© Ingenix, Inc. 5CONFIDENTIAL & PROPRIETARY
Impact Pro Suite
© Ingenix, Inc. 6CONFIDENTIAL & PROPRIETARY
Clinical Indicators– Disease prevalence– Disease stage, advanced markers– Significant medical and pharmacy utilization events– More than 1,000 markers available– Rules engine to support custom rules
Care Opportunities– Gaps in care based on comparisons with evidence-
based medicine and guidelines– Future – supplemented by Symmetry’s EBM
Connect– Rules engine to support custom rules
Impact ProActive – Features
© Ingenix, Inc. 7CONFIDENTIAL & PROPRIETARY
Care Teams– Identify key providers for a patient based on
observed interaction with the healthcare system
– In addition to PCP, Team defined for selected conditions, including diabetes, cardiovascular, and cancer
Case Definitions– Create any cohort of patients, using all Impact Pro
outputs and member attributes
– Actionability and savings Assumptions
Standard Rules and User-Defined Utilities
Impact ProActive – Features (cont)
© Ingenix, Inc. 8CONFIDENTIAL & PROPRIETARY
Agenda Topics
Introduction and IPRO refresher Introduction to Self Report Domains Current Self Report IPRO incorporation
Impact Pro Active Filtering Case Definitions Limitations in current self report IPRO approach
Introduction of HMG Making the business case HMG introduction Self Report standardization HMG testing with obesity, smoking and nutrition
Additional Questions
© Ingenix, Inc. 9CONFIDENTIAL & PROPRIETARY
Introduction to Self Reported MeasurementSurvey Domains
© Ingenix, Inc. 10CONFIDENTIAL & PROPRIETARY
Standardized survey tools
HRAs Industry tools (dozens) and CDC’s BRFSS
HRQOL Generic Assess the health related quality of life of a population
– SF-36, NHP, SIP, Dartmouth COOP charts Disease-specific HRQOL measures
– St. George’s Respiratory Questionnaire– MOS-HIV instrument
Productivity Gold Book (2001): covered a number of instruments IHPM leads the way today in this regard today
Behavioral Health Clinical diagnostic assessments used in behavioral health that are administered via survey Psychological assessments, including substance use and abuse
Patient Activation measures Prochaska TTM; Hibbard’s Activation measures
Non-standardized tools Home-grown assessments when working with patients
Values in health care CAHPS and home grown satisfaction surveys Medical decision making surveys
© Ingenix, Inc. 11CONFIDENTIAL & PROPRIETARY
Challenges on assessing Self Report
Descriptive statistics (ceiling/floor effects and missing data) Test-Retest Reliability Item Internal consistency Equality of Item-Scale Correlations Item Discriminant Validity Reliability (Cronbach’s alpha) Construct Validity Respondent burden Languages
Various tests based on type of items present in your self report measure database
MAP-R for Likert-based scales is a useful tool (Ware, Hays have versions available)
© Ingenix, Inc. 12CONFIDENTIAL & PROPRIETARY
Strength of self reported measurement
Highly reliable instruments are used Valid with clinical and cost measures Measure domains not accessible by administrative data
Health behaviors and attitudes Health states, pain and function and disease severity Mental health indicators Perceptions of productivity impacted by health Values around medical decisions Satisfaction with health care Social Support
Validating your measurement See predicted response and benchmark with norms
© Ingenix, Inc. 13CONFIDENTIAL & PROPRIETARY
Agenda Topics
Introduction and IPRO refresher Self Report Domains Current Self Report IPRO incorporation
Impact Pro Active Filtering Case Definitions Limitations in current self report IPRO approach
Introduction of HMG Making the business case HMG introduction Self Report standardization HMG testing with obesity, smoking and nutrition
Additional Questions
© Ingenix, Inc. 14CONFIDENTIAL & PROPRIETARY
Current Self Report IPRO incorporation
Today self report data (examples of HRA data) is “passed through” Impact Pro
However, IPRO can organize self report survey questions, which can then be used to View, select or report on a population
There is a defined HRA or survey table structure Clients have to prepare their self-report survey
questions into meaningful categories to filter on or create further case definitions
Following key principles to validate your data – (notes validation slides)
© Ingenix, Inc. 15CONFIDENTIAL & PROPRIETARY
Seeing Self Reported Data in IPRO 5.0 – member list
© Ingenix, Inc. 16CONFIDENTIAL & PROPRIETARY
Seeing Self Reported Data in IPRO 5.0 – HRA tab
© Ingenix, Inc. 17CONFIDENTIAL & PROPRIETARY
Filtering on HRA data
Can also create case definitions using HRA data and Impact Pro
© Ingenix, Inc. 18CONFIDENTIAL & PROPRIETARY
Filtering can take a few forms
To include or exclude members with all HRA responses for a particular survey All members that also took an HRA
To include members with a sub-set of responses to particular survey questions All members that reported missing work days frequently do to health
To create AND statements within the entries within the Included or Excluded boxes, or to create a combination of AND/OR statements between selections within the Included or Excluded boxes
Advanced Filters allows you to create AND statements or a combination of AND/OR statements between selections within the (Included or Excluded) boxes
Filtered records can also be reported on through customized reports within the IPRO reporting engine.
© Ingenix, Inc. 19CONFIDENTIAL & PROPRIETARY
Case Definitions
Rules to identify sub-sets of members who meet certain criteria
Allow you to see how many different sets of criteria an individual member meets
Allow you to create a hierarchy or prioritization of criteria (Impact Score)
Allow you to pre-determine anticipated savings per criteria set (Predicted Savings)
© Ingenix, Inc. 20CONFIDENTIAL & PROPRIETARY
• Unlike Filters which query data that has already been processed, creating a Case Definition is creating a Rule to be run through the Processing Engine – results will not be seen until the next data run
NOTE: This is true for ALL rules – Clinical Indicators, Care Opportunities and Case Definitions
• Once the Rule has been created though, it will be persistent for every future data run AND it can be used as a Filter itself.
Creating a Case Definition
© Ingenix, Inc. 21CONFIDENTIAL & PROPRIETARY
Using Impact Score to Stratify Disease Management
Moderate Impact Diabetes Risk Category = Diabetes…and Risk Score = 7-24….and Care Opportunity
– New Insulin Rx…..or– New oral Hypoglycemic Rx…..or– Gaps in refills or no refills for oral hypoglycemic agents…….and
Case Definition– Exclude members who meet Case Definition of “High Impact – Diabetes”– Include members with stages of change self report question related to
improvement of diet
37 Ingenix created Case Definitions “out of the box” 37 Ingenix created Case Definitions “out of the box” for demonstration purposes onlyfor demonstration purposes only
© Ingenix, Inc. 22CONFIDENTIAL & PROPRIETARY
Limitations of existing HRA functionality in IPRO
No standardization of HRA data from various sources Clients are left to create their own standards
No use of national standards with some self-report concepts that are widely understood and can add further depth to understanding health (e.g. CDC definitions) Similar to an EBM type model
The processing engine does not use the data for further calculation of cost and risk in a precise way
No current way to reconcile contradictions between administrative claims and self report data
No current way to build multi-dimensional variables with distinct levels that combine HRA, lab and administrative claims presently
Leads us to address many of these limitations
© Ingenix, Inc. 23CONFIDENTIAL & PROPRIETARY
Agenda Topics
Introduction and IPRO refresher Self Report Domains Current Self Report IPRO incorporation
Impact Pro Active Filtering Case Definitions Limitations in current self report IPRO approach
Introduction of HMG Making the business case Self report standardization HMG introduction HMG testing with smoking, physical activity, nutrition and obesity
Additional Questions
© Ingenix, Inc. 24CONFIDENTIAL & PROPRIETARY
HMGs – Making the business case
Information tools and methodologies to support care and health management – current state: Primary focus is on disease populations or individuals of
moderate to higher risk Clinical information and concepts supported by administrative
medical and pharmacy claims, some use clinical data Outputs include measures of risk, some add gaps in care Many tools add reporting and some cohort modeling capabilities Limited use of alternative sources of data today Include alternative sources for identification and stratification
methods, prediction and risk adjustment– How can data from various sources be combined into meaningful
building blocks of information?
© Ingenix, Inc. 25CONFIDENTIAL & PROPRIETARY
HMGs – Making the business case
Health care organizations and employers are increasingly interested in focusing on healthier members in a population, or members of emerging risk Extend interventions to the lower end of the risk spectrum Improve wellness, healthy behaviors and lifestyle Improve attitudes on health Intervene in a more pro-active way, e.g., pre-diabetes, and
diabetes-risk
© Ingenix, Inc. 26CONFIDENTIAL & PROPRIETARY
Segmenting Populations
Maintain Health Manage HealthImprove Health
• 57% of population has claims under $1,000
• 8% of total medical expenses are spent by this group
• 41% of population has claims between $1,000 and $20,000
• 59% of total medical expenses are spent by this group
• 2% of population has claims greater than $20,000
• 33% of total medical expenses are spent by this group
Moving Forward: Enhanced Information for Health Solutions
Source: National Health Plan Fully Insured Book of Business, 2004
Current Focus
Acute Conditions
Moderate Risk High Risk Catastrophic Illness
Low Risk Chronic Disease
© Ingenix, Inc. 27CONFIDENTIAL & PROPRIETARY
Change of Focus and Requirements
Support analysis of healthier populations and patients of emerging risk
Leverage existing and new sources of data, including HRA/self report, biometric data and socio-economic data
Integrate these different sources of data in innovative ways: Improve on existing concepts, e.g., measures of future risk Support new domains of measurement, including behaviors, attitudes,
and social context Accommodate different data scenarios – consistent data
availability unlikely across and within populations Create a useful context for analysis
We are pulling together a larger number of concepts and variables than are currently available in Impact Pro
Add value for customers by developing a context – organize information for analysis, presentation, and operations – in a flexible way
© Ingenix, Inc. 28CONFIDENTIAL & PROPRIETARY
Health Management Group Concepts and Domains
Ingenix HMG will provide methodologies and outputs to measure individuals along different domains that describe health
HMGs provide a context for integrating five domains of health
Domains support both identification/stratification and further segmentation
Risk and Severity
Health Management
Groups (HMGs)
Clinical
Health Behaviors
Social Context
Health Attitudes
© Ingenix, Inc. 29CONFIDENTIAL & PROPRIETARY
HMG Concepts and Domains
Information and domains to support identification and stratification: Clinical
– A clinical description of an individual, based on diagnostic, drug and procedural claims available in Impact Pro and through HRA self report
– Examples – diabetes, CHF, depression, sleep disorder, obesity
Risk or Severity– Impact Pro risk, ETG severity, Self report of severity
– Examples – future risk, condition episode severity, health status
Behavior (Healthy behaviors)– HRA and EBM measures of behavior, behaviors inferred from
consumer data (future)
– Examples – smoking, physical activity, compliance with EBM chronic and preventive rules
© Ingenix, Inc. 30CONFIDENTIAL & PROPRIETARY
HMG Concepts and Domains
Further segmentation can occur with: Attitudes and ratings related to health
– Readiness to change, activation and perceived social support– Productivity: absenteeism and presenteeism impacted by health
Social Context– Ascribed and achieved status found on HRA and administrative data– Examples – Age, gender, race ethnicity, education, income, SES
HMGs will provide a context for organizing patient information around the five domains
HMGs are being built for specific conditions and behavioral concepts HMG Levels will be defined to support identification and
stratification
© Ingenix, Inc. 31CONFIDENTIAL & PROPRIETARY
HMG Concepts and Domains
The HMG methodology will: Leverage existing Ingenix technologies (Impact Pro, ETG,
EBM Connect), but expand their focus to new populations and types of measures
Introduce new sources of data and methods to improve on existing concepts and support new concepts
Integrate data from multiple sources to describe and categorize a patient along each domain
Define key building blocks and categorizations within each HMG
– Includes frequency of events and actions, timing (associated with different data sources) and depth of HMG level
© Ingenix, Inc. 32CONFIDENTIAL & PROPRIETARY
Key Advance: HMG Standardizes Alternative sources of data
The HMG methodology will: Standardize self report and biometric data found on HRAs and
other surveys into meaningful sets of building blocks– Smokers: current, quitting, former never– BMI: underweight, normal weight, overweight, obese and morbidly
obese– We call these standardized measures dimensional concepts
Will require the user to map their items through a standardized common HRA map with leading HRA tools in the field
– Also maintain flexibility for the user to develop meaningful HRA categories or build case definitions present in Impact Pro Active
We will use a scoring framework to map variable attributes into consistent scores and indicators of risk
© Ingenix, Inc. 33CONFIDENTIAL & PROPRIETARY
Key Advance: HMG Standardizes self-report data
Standardized self-reported concepts include: Condition, treatment, utilization via self report Health behaviors: lifestyle, preventive testing, immunizations,
safety and other forms of risk aversion Health attitudes: readiness, activation and awareness HRQOL: physical, emotional, bodily pain, role function Productivity: absenteeism and presenteeism Social Support Social Context: race, ethnicity, education, income Biometric markers: cholesterol, BMI, BP, etc.
This data could extend the risk spectrum for those that answer an HRA and some variables could be used to tailor communication and intervention
© Ingenix, Inc. 34CONFIDENTIAL & PROPRIETARY
Examples of HMGs under development
Disease Management Wellness-Related
Asthma/COPD Smoking
CAD Physical Activity
Diabetes Safety
Back Problems Stress
Depression Alcohol Abuse
Obesity Sexual Risk Activity
Sleep Problems Nutrition
Migraine Headaches *preliminary results to be presented
© Ingenix, Inc. 35CONFIDENTIAL & PROPRIETARY
Current HMG Development
Scope out identification and stratification algorithms for HMGs Solicit clinical input and review
Apply algorithms to current analytic data warehouse that has claims, lab and HRA for seven large employers Interested in other clients participating in this process
Test hypotheses related to expected levels associated with HMGs to see if levels are distinct and valid
Begin to look at emerging risk associated with certain behaviors or conditions
© Ingenix, Inc. 36CONFIDENTIAL & PROPRIETARY
Smoking-Related HMG
HMG Levels Current Quitting Former smoker Never smoked
Information used to identify and stratify HRA: smoking status, quantity of use, quitting stage Medical and pharmacy: diagnoses, drug therapies, procedures indicating
quit attempts, quit treatments and counseling Map relevant clinical and family history to further define levels
Ask ourselves: If I run a smoking cessation program what would I want to understand about my members? Levels of smoking use How does smoking relate to cost and risk? What does the emerging risk across smoking groups look like?
© Ingenix, Inc. 37CONFIDENTIAL & PROPRIETARY
Smoking Results
Smoking Distribution
62.7%
15.8%
3.9%
17.6%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
Never Former Quitting Current
© Ingenix, Inc. 38CONFIDENTIAL & PROPRIETARY
Smoking Results by Cost and Risk
Cigarette Use by Cost, Imputed
$276$317
$656
$578
$0.00
$100.00
$200.00
$300.00
$400.00
$500.00
$600.00
$700.00
$800.00
Never Former Quitting Current
Cigarette Use by IPRO Risk
1.21
1.41
2.59
2.00
0.00
0.50
1.00
1.50
2.00
2.50
3.00
Never Former Quitting Current
© Ingenix, Inc. 39CONFIDENTIAL & PROPRIETARY
Tobacco Use w ithin Risk Groups
36%29%
19%11% 9% 8%
9% 21% 35%41%
38%
51%
33%28%
21%14% 10% 10%
30%
43%35%
21.8%
25%
22%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
<0.5 -1.5 -3.0 -5.0 -10 >10
Never Former Quitting Using
Smoking Results – Emerging Risk
© Ingenix, Inc. 40CONFIDENTIAL & PROPRIETARY
Smoking Results by Health Status and Lost Work Days
Self-Reported Health by Cigarette Use
77.12% 77.14%
69.73% 69.28%
0.00%
20.00%
40.00%
60.00%
80.00%
100.00%
Never Former Quitting Current
Average Days Absent by Cigarette Use
1.6
1.8
0.8
2.3
0.00
1.00
2.00
3.00
Never Former Quitting Current
© Ingenix, Inc. 41CONFIDENTIAL & PROPRIETARY
Physical Activity HMG
HMG Levels Active, complete – goes beyond CDC definitions Active, sufficient – meets CDC definitions Active, light – falls below CDC definitions Active, insufficient – falls far below CDC definitions Inactive
Information used to identify and stratify HRA: many physical, exercise items to standardize Medical and pharmacy: limited set of procedures to increase or counsel
on PA
Ask ourselves: If I run a PA program, program what would I want to understand about my members? Levels of activity How does PA relate to cost and risk? What does the emerging risk of inactivity look like?
© Ingenix, Inc. 42CONFIDENTIAL & PROPRIETARY
Physical Activity - Identification
Physical Activity Levels
28.9%
19.0%
37.6%
9.6%
5.0%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
Complete Activity Sufficient Activity Light Activity Insufficient Activity Inactive
© Ingenix, Inc. 43CONFIDENTIAL & PROPRIETARY
Physical Activity – Cost and Risk
Physical Activity by Cost, PMPM
$230
$265 $275
$239
$394
$0.00
$50.00
$100.00
$150.00
$200.00
$250.00
$300.00
$350.00
$400.00
$450.00
$500.00
Complete Activity Sufficient Activity Light Activity Insufficient Activity Inactive
Physical Activity by IPRO Risk
1.08
1.47
1.30
1.42
1.79
0.8
1.0
1.2
1.4
1.6
1.8
2.0
Complete Activity Sufficient Activity Light Activity Insufficient Activity Inactive
© Ingenix, Inc. 44CONFIDENTIAL & PROPRIETARY
Physical Activity – Emerging Risk
Physical Activity w ithin Risk Groups
26%20% 16% 12% 10% 9%
19%
20%21%
22%21% 20%
21%
20% 19%17%
17% 19%
20%
20%20%
21% 25% 21%
14%21% 24% 28% 27% 30%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
<0.5 -1.5 -3.0 -5.0 -10 >10
Complete Suff icient Light Insuff icient Inactive
© Ingenix, Inc. 45CONFIDENTIAL & PROPRIETARY
Physical Activity – Health Status and Work Absence
Self-Reported Health by Physical Activity
79.0%72.6%
69.6%64.3%
60.9%
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
Complete Activity Sufficient Activity Light Activity InsufficientActivity
Inactive
Average Days Absent by Physical Activity
1.9
2.32.1
2.3
3.7
0.0
1.0
2.0
3.0
4.0
Complete Activity Sufficient Activity Light Activity Insufficient Activity Inactive
© Ingenix, Inc. 46CONFIDENTIAL & PROPRIETARY
Nutrition HMG
HMG Levels Severe nutrition problems Moderate nutrition problems Low nutrition problems No nutrition problems
Information used to identify and stratify Medical and pharmacy: nutrition and weight management counseling
appointments and obesity HMG (claims and biometric data) HRA: items related to nutrition behaviors and choices
Ask ourselves: If I run a nutrition behavior change program what would I want to understand about my members before enacting programming? Levels of nutrition problems How do nutrition problems relate to cost and risk? What does the emerging risk across nutrition groups look like?
© Ingenix, Inc. 47CONFIDENTIAL & PROPRIETARY
Nutrition Problems - Identification
Nutrition Problems
10.1%
50.9%
33.7%
5.4%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
None Low Medium High
Nutrition Problems Identification
47.78%43.30%
35.19%
100.00%
52.22%56.70%
64.81%
0.00%
20.00%
40.00%
60.00%
80.00%
100.00%
120.00%
1 2 3 4
Claims
HRA
© Ingenix, Inc. 48CONFIDENTIAL & PROPRIETARY
Nutrition Results – Cost and RiskNutrition Problems by Cost
$289.68$260.41
$309.93
$576.80
$0.00
$100.00
$200.00
$300.00
$400.00
$500.00
$600.00
$700.00
None Low Medium High
Nutrition Problems
Nutrition Problems by IPRO Risk
1.19 1.22
1.36
1.78
0.8
1
1.2
1.4
1.6
1.8
2
None Low Medium High
Nutrition Problems
© Ingenix, Inc. 49CONFIDENTIAL & PROPRIETARY
Nutrition Results – Emerging Risk
Nutrition Problems by IPRO Risk Score
9.80% 11.00% 9.00% 7.00% 8.00% 10.00%
53.50% 52.00%46.00% 45.00% 41.00% 40.00%
32.40% 32.00%38.00% 39.00%
38.00% 36.00%
4.30% 5.00% 7.00% 9.00% 13.00% 13.00%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0-.5 .501-1.5 1.501 - 3.0 3.01 - 5.0 5.01 - 10.0 10.01
High
Medium
Low
None
Nutrition Problems by PMPM Ranges
10.00% 10.00% 11.00% 10.00%
53.00% 51.00% 49.00% 45.00%
33.00% 34.00% 36.00%36.00%
5.00% 5.00% 5.00% 9.00%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
$0 - $100 $101 - $200 $201 - $350 $351+
High
Medium
Low
None
© Ingenix, Inc. 50CONFIDENTIAL & PROPRIETARY
Nutrition Results – Health Status and Work Absence
Nutrition Problems Related to Health Status
8478
7166
0
10
20
30
40
50
60
70
80
90
100
None Low Medium High
100 =
best
healt
h
Absent Days by Nutrition Problems
2.01
1.64
2.23
3.58
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
None Low Medium High
© Ingenix, Inc. 51CONFIDENTIAL & PROPRIETARY
Obesity HMG
HMG Levels Morbidly Obese Obese Overweight Normal weight Underweight
Information used to identify and stratify Medical and pharmacy: BMI, obesity diagnoses, obesity
procedures, complications associated with obesity, obesity DCC’s.
HRA: BMI and Waist circumference
© Ingenix, Inc. 52CONFIDENTIAL & PROPRIETARY
Obesity Problems - IdentificationFinal obesity levels (n=26184)
1.0%
34.2%
38.1%
23.1%
3.6%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
45.0%
Underw eight Healthy w eight Overw eight Obese Morbidly Obese
Obesity levels
Obesity Levels Identification
12.63%
29.09%
100.00% 100.00% 100.00%
87.37%
70.91%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
Underweight Healthyweight
Overweight Obese MorbidlyObese
Claims
HRA
© Ingenix, Inc. 53CONFIDENTIAL & PROPRIETARY
Obesity Results – Cost and Risk
Obesity levels by IPRO Risk
1.11.17 1.18
1.52
2.16
0.8
1
1.2
1.4
1.6
1.8
2
2.2
2.4
Underw eight Healthy w eight Overw eight Obese Morbidly Obese
Obesity levels
Obesity levels by Cost
$230.00
$284.00$254.00
$347.00
$632.00
$0.00
$100.00
$200.00
$300.00
$400.00
$500.00
$600.00
$700.00
Underw eight Healthy w eight Overw eight Obese Morbidly Obese
Obesity levels
© Ingenix, Inc. 54CONFIDENTIAL & PROPRIETARY
Obesity Results – Emerging Risk
Obesity Problems by PMPM Ranges
35.22% 35.01% 32.99% 30.59%
40.71% 37.01% 36.12%33.06%
20.79% 23.69% 26.06%28.11%
2.23% 3.50% 3.94% 7.14%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
$0 - $100 $101 - $200 $201 - $350 $351+
Morbidly Obese
Obese
Overweight
Healthy weight
Underweight
Obesity Problems by IPRO Risk Score
36.93% 35.81%28.39% 26.24% 27.98% 30.09%
42.13%38.06%
35.03% 33.90% 27.98% 27.43%
18.36%22.08%
30.10% 31.11%31.35% 30.09%
1.44% 3.01% 5.75% 7.66% 12.10% 11.50%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0-.5 .501-1.5 1.501 - 3.0 3.01 - 5.0 5.01 - 10.0 10.001 +
Morbidly Obese
Obese
Overweight
Healthy weight
Underweight
© Ingenix, Inc. 55CONFIDENTIAL & PROPRIETARY
Obesity Results – Health Status and Work Absence
Obesity level related to health status
7581
77
68
60
20
30
40
50
60
70
80
90
100
Underweight Healthyweight
Overweight Obese MorbidlyObese
Obesity levels
Absent days by obesity level
21.8 1.7
2.4
3.9
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
Underweight Healthy weight Overweight Obese Morbidly Obese
Obesity levels
© Ingenix, Inc. 56CONFIDENTIAL & PROPRIETARY
Obesity Results – Diabetes and Obesity
Proportion of diabetics by obesity HMG level
0.33%
12.38%
25.36%
46.95%
14.98%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
50.00%
Underweight Healthy weight Overweight Obese Morbidly Obese
Obesity HMG level
© Ingenix, Inc. 57CONFIDENTIAL & PROPRIETARY
HMG Summary
Provide a context to organize and focus information in a way that is consistent from both a clinical perspective and also from a health management operational perspective
Describe both clinical and wellness intervention opportunities Have defined levels – that map to potential cohorts for intervention –
e.g., level of acuity; categories of smoking status; level of physical activity
Have rules and algorithms that assign an individual to a clinical or behavioral status (HMG) and levels of problems within an HMG (reconcile data sources, conflicts, timing, frequency) Allow users to further define or combine levels that fit program goals
using Impact Pro Active
Incorporate methods to accommodate different data availability scenarios for each individual
© Ingenix, Inc. 58CONFIDENTIAL & PROPRIETARY
Questions/Comments
© Ingenix, Inc. 59CONFIDENTIAL & PROPRIETARY
Appendix
HRA Input Slides from Impact Pro manual
© Ingenix, Inc. 60CONFIDENTIAL & PROPRIETARY
Assessing and Validating HRA Inputs - appendix
Validity and reliability of input data is key to its use not only with claims data, but also with self report
With self report, you want to see key elements that are included in the input tables, pass through properly, and can be used for filtering and selecting patients Answer_Desc: Each answer should be unique, and should provide
information about the question the answer responds to. For example, an appropriate answer description is “Yes, I am a smoker.”
Quest_Desc: Each answer should be unique, and should provide information about the question topic. For example, an appropriate question description is “Do you smoke?” An inappropriate response description is “Question 1.”
Impact Pro uses the MEMBER field to uniquely link information regarding each member to the Impact Pro output datamart. MEMBER should uniquely define an individual. Every member ID in the HRADATA table must also have an entry in the MEMBER table.
Lastly, check to see number of questions and members is correct and duplicates and invalid records indicated in the validation output.
© Ingenix, Inc. 61CONFIDENTIAL & PROPRIETARY
HRA Table Structure - appendix
© Ingenix, Inc. 62CONFIDENTIAL & PROPRIETARY
HRA Table Structure - appendix
© Ingenix, Inc. 63CONFIDENTIAL & PROPRIETARY
HRA Table Structure - appendix
© Ingenix, Inc. 64CONFIDENTIAL & PROPRIETARY
HRA Table Structure - appendix
© Ingenix, Inc. 65CONFIDENTIAL & PROPRIETARY
Input data steps to include HRA data - appendix
© Ingenix, Inc. 66CONFIDENTIAL & PROPRIETARY
Input and Output Data Steps – HRA considerations - appendix